AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GUNSYND PLC

Share Issue/Capital Change Mar 28, 2024

7684_rns_2024-03-28_6b6f986b-1ec0-46c4-939d-fac0f71c4df3.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7862I

Gunsynd PLC

28 March 2024

Gunsynd PLC

("Gunsynd" or the "Company")

Issue of Equity

Gunsynd (AIM: GUN; AQSE: GUN) announces that it has issued 17,000,000 new ordinary shares to settle a liability to the value of £24,000 ("Fee Shares").

Admission

Application will be made to the London Stock Exchange to admit the Fee Shares to trading on AIM and to the Aquis Stock Exchange Growth Market ("Admission"). Admission of the new ordinary shares is expected to occur on or around 5 April 2024. The Fee Shares will rank pari passu with the existing ordinary shares.

Total Voting Rights

For the purpose of the Disclosure and Transparency Rules, following Admission, the enlarged issued share capital of the Company will comprise 571,796,506 ordinary shares of 0.085p each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information please contact:

Gunsynd plc

Hamish Harris/ Peter Ruse

  www.gunsynd.com
+44 (0)7879 584 153
Cairn Financial Advisers LLP

James Caithie / Liam Murray
+44 (0)20 7213 0880
Peterhouse Capital Limited

Lucy Williams
+44 (0)20 7469 0936

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEBLGDXGGDDGSI

Talk to a Data Expert

Have a question? We'll get back to you promptly.